Sphingosine Kinase 1 and Sphingosine-1-Phosphate in Oxidative Stress Evoked by 1-Methyl-4-Phenylpyridinium (MPP+) in Human Dopaminergic Neuronal Cells

[1]  S. Pitson,et al.  Roles, regulation and inhibitors of sphingosine kinase 2 , 2013, The FEBS journal.

[2]  Ruzhu Chen,et al.  Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway. , 2013, European journal of pharmacology.

[3]  Dick F. Swaab,et al.  Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling , 2013, PloS one.

[4]  Yi Sun,et al.  3-O-demethylswertipunicoside inhibits MPP+-induced oxidative stress and apoptosis in PC12 cells , 2013, Brain Research.

[5]  L. Obeid,et al.  Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway. , 2013, Handbook of experimental pharmacology.

[6]  Jing Wang,et al.  Mechanisms of MPP+-induced PC12 cell apoptosis via reactive oxygen species , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[7]  Takehiko Sasaki,et al.  Essential Role of Class II Phosphatidylinositol-3-kinase-C2α in Sphingosine 1-Phosphate Receptor-1-mediated Signaling and Migration in Endothelial Cells* , 2012, The Journal of Biological Chemistry.

[8]  O. Cuvillier.  Les récepteurs de la sphingosine 1-phosphate : De la biologie à la physiopathologie , 2012 .

[9]  A. Iwase,et al.  Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. , 2012, Fertility and sterility.

[10]  Y. Okamoto,et al.  Sphingosine‐1‐phosphate signaling in physiology and diseases , 2012, BioFactors.

[11]  L. Soane,et al.  A New View of the Lethal Apoptotic Pore , 2012, PLoS biology.

[12]  Joseph B. Williams,et al.  The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. , 2012, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[13]  D. Damania,et al.  Sphingosine Kinase 1 Deficiency Exacerbates LPS-Induced Neuroinflammation , 2012, PloS one.

[14]  T. Kuwana,et al.  Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis , 2012, Cell.

[15]  O. Cuvillier.  [Sphingosine 1-phosphate receptors: from biology to physiopathology]. , 2012, Medecine sciences : M/S.

[16]  Sheng-gang Sun 孙圣刚,et al.  Mechanisms of MPP+-induced PC12 cell apoptosis via reactive oxygen species , 2012, Journal of Huazhong University of Science and Technology [Medical Sciences].

[17]  G. Gao,et al.  Astragaloside IV prevents MPP+-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production , 2012, Molecular and Cellular Biochemistry.

[18]  S. Barrera-Vilarmau,et al.  Intrinsic Order and Disorder in the Bcl-2 Member Harakiri: Insights into Its Proapoptotic Activity , 2011, PloS one.

[19]  J. Trojanowski,et al.  BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate , 2011, The Journal of Neuroscience.

[20]  Xiaobing Li,et al.  Protection by tetrahydroxystilbene glucoside against neurotoxicity induced by MPP+: the involvement of PI3K/Akt pathway activation. , 2011, Toxicology letters.

[21]  P. Xia,et al.  Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. , 2011, Cytokine & growth factor reviews.

[22]  D. C. Simpson,et al.  Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  S. Pitson.  Regulation of sphingosine kinase and sphingolipid signaling. , 2011, Trends in biochemical sciences.

[24]  J. Pfeilschifter,et al.  Loss of sphingosine kinase‐1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin‐induced DNA damage , 2011, British journal of pharmacology.

[25]  E. Lo,et al.  Fingolimod provides long‐term protection in rodent models of cerebral ischemia , 2011, Annals of neurology.

[26]  Sarah Spiegel,et al.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature , 2010, Pharmacological Reviews.

[27]  J. Bian,et al.  Protective effect of hydrogen sulphide against 6‐OHDA‐induced cell injury in SH‐SY5Y cells involves PKC/PI3K/Akt pathway , 2010, British journal of pharmacology.

[28]  Mark P Mattson,et al.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. , 2010, Biochimica et biophysica acta.

[29]  H. Fyrst,et al.  An update on sphingosine-1-phosphate and other sphingolipid mediators. , 2010, Nature chemical biology.

[30]  S. Pitson,et al.  Inhibitors of the sphingosine kinase pathway as potential therapeutics. , 2010, Current cancer drug targets.

[31]  B. Brüne,et al.  Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. , 2010, Blood.

[32]  Hong-rong Xie,et al.  SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. , 2010, Chinese medical journal.

[33]  O. Pabst,et al.  Redistribution of Sphingosine 1-Phosphate by Sphingosine Kinase 2 Contributes to Lymphopenia , 2010, The Journal of Immunology.

[34]  C. Gong,et al.  Deregulation of sphingolipid metabolism in Alzheimer's disease , 2010, Neurobiology of Aging.

[35]  Junxia Xie,et al.  Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-κB modulation in MES23.5 cells , 2010, Experimental Neurology.

[36]  N. Rotstein,et al.  Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors. , 2010, Investigative ophthalmology & visual science.

[37]  Sarah Spiegel,et al.  Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2* , 2010, The Journal of Biological Chemistry.

[38]  C. Sato-Bigbee,et al.  FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. , 2009, Journal of neurotrauma.

[39]  P. Xia,et al.  Role of sphingolipids in the cytoplasmic signaling of estrogens , 2009, Steroids.

[40]  A. Stępień,et al.  Involvement of multiple protein kinases in cPLA2 phosphorylation, arachidonic acid release, and cell death in in vivo and in vitro models of 1‐methyl‐4‐phenylpyridinium‐induced parkinsonism – the possible key role of PKG , 2009, Journal of neurochemistry.

[41]  T. Okada,et al.  Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system. , 2009, Cellular signalling.

[42]  Kwok-Fai So,et al.  Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. , 2009, Neurotoxicology.

[43]  Sabine Borwege,et al.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists , 2009, Neurotoxicity Research.

[44]  M. Ebadi,et al.  1-Methyl-4-phenyl-pyridinium ion-induced oxidative stress, c-Jun phosphorylation and DNA fragmentation factor-45 cleavage in SK-N-SH cells are averted by selegiline , 2008, Neurochemistry International.

[45]  Libing Song,et al.  Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival , 2008, Clinical Cancer Research.

[46]  O. Cuvillier,et al.  Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. , 2008, Cancer research.

[47]  Sarah Spiegel,et al.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. , 2008, Journal of lipid research.

[48]  J. McArthur,et al.  Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. , 2008, Frontiers in bioscience : a journal and virtual library.

[49]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[50]  A. Melendez.  Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. , 2008, Biochimica et biophysica acta.

[51]  M. Maddelein,et al.  Critical Role for Sphingosine Kinase-1 in Regulating Survival of Neuroblastoma Cells Exposed to Amyloid-β Peptide , 2007, Molecular Pharmacology.

[52]  K. Jakobs,et al.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. , 2007, Biochimica et biophysica acta.

[53]  V. Haroutunian,et al.  Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease? , 2007, Neurochemical Research.

[54]  S. Milstien,et al.  Shooting the messenger: oxidative stress regulates sphingosine-1-phosphate. , 2007, Circulation research.

[55]  O. Kunduzova,et al.  Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis , 2007, Circulation research.

[56]  E. Billett,et al.  The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells , 2006, Neuroscience Letters.

[57]  M. Zhang,et al.  SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism* , 2005, Journal of Biological Chemistry.

[58]  Thomas W Prior,et al.  Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines , 2005, Journal of neuropathology and experimental neurology.

[59]  J. Gamble,et al.  Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. , 2005, Blood.

[60]  S. Spiegel,et al.  Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression , 2005, Oncogene.

[61]  M. Naoi,et al.  Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system , 2005, Journal of Neural Transmission / General Section JNT.

[62]  E. Goetzl,et al.  Sphingosine Kinase Activation Mediates Ischemic Preconditioning in Murine Heart , 2004, Circulation.

[63]  L. Obeid,et al.  Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. , 2004, Biochimica et biophysica acta.

[64]  P. Eisenhauer,et al.  cDNA Microarray Analysis of Changes in Gene Expression Associated with MPP+ Toxicity in SH-SY5Y Cells , 2003, Neurochemical Research.

[65]  T. Okada,et al.  Sphingosine Kinase 2 Is a Nuclear Protein and Inhibits DNA Synthesis* , 2003, Journal of Biological Chemistry.

[66]  J. Bennett,et al.  Dependence on electron transport chain function and intracellular signaling of genomic responses in SH-SY5Y cells to the mitochondrial neurotoxin MPP+ , 2003, Experimental Neurology.

[67]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[68]  J. McCubrey,et al.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.

[69]  M. Maceyka,et al.  Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. , 2002, Biochimica et biophysica acta.

[70]  K. Lynch,et al.  Lysophospholipid receptor nomenclature. , 2002, Biochimica et biophysica acta.

[71]  S. R. Datta,et al.  Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway , 2001, Current Opinion in Neurobiology.

[72]  S. Spiegel,et al.  Sphingosine kinase: a mediator of vital cellular functions. , 2001, Prostaglandins & other lipid mediators.

[73]  S. Milstien,et al.  Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells , 2001, Journal of neurochemistry.

[74]  C. Fall,et al.  Disrupted mitochondrial electron transport function increases expression of anti‐apoptotic Bcl‐2 and Bcl‐XL proteins in SH‐SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress , 2000, Journal of neuroscience research.

[75]  S. Pyne,et al.  Sphingosine 1-phosphate signalling in mammalian cells. , 2000, The Biochemical journal.

[76]  T. Furuyama,et al.  The Cell Death-promoting Gene DP5, Which Interacts with the BCL2 Family, Is Induced during Neuronal Apoptosis Following Exposure to Amyloid β Protein* , 1999, The Journal of Biological Chemistry.

[77]  Y. Nomura,et al.  1-Methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms , 1995, Brain Research.

[78]  P. Fleming,et al.  Multiple forms of human dopamine β-hydroxylase in SH-SY5Y neuroblastoma cells☆ , 1991 .

[79]  P. Fleming,et al.  Multiple forms of human dopamine beta-hydroxylase in SH-SY5Y neuroblastoma cells. , 1991, Archives of biochemistry and biophysics.